Leonard Klevan, Ph.D.
Division President, Applied Markets Division
Applied Biosystems

Dr. Klevan is responsible for defining and executing strategic direction for the company's Applied Markets division, which produces and markets reagent kits for forensic DNA, paternity testing and other forms of human identification as well as products for biosecurity, food/agriculture, and environmental applications.

Prior to his current position, Dr. Klevan was Vice President of R&D for the Applied Markets division. Prior to joining Applied Biosystems, he was Chief Executive Officer of ReliaGene Technologies, a forensic and paternity testing laboratory and previously he was President and CEO of MiraiBio (Hitachi Genetic Systems), a subsidiary of Hitachi Software Engineering. Earlier in his career, Dr. Klevan managed technology acquisition and business development for Life Technologies.

Dr. Klevan has a BA in Chemistry from the State University of New York and a Ph.D. in Physical Chemistry from Yale University.

Website Feedback